Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Walgreens Boots Alliance Inc (WBA) Insider Trading Activity
Healthcare • Pharmaceutical Retailers • 193,000 employees
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise. The International segment offers sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile. The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients' homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors. Walgreens Boots Alliance, Inc. was founded in 1909 and is headquartered in Deerfield, Illinois.
Total Value
-$1,513,069,283,420.93
Total Shares
-13,326,208
Average Trade Value
-$32,892,810,509.15
Most Active Insider
Walgreens Boots Alliance, Inc.
Total Activity: $1,513,067,646,416
Largest Single Transaction
$1,512,000,000,000
by Walgreens Boots Alliance, Inc. on Sep 11, 2024
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
Svp, Global Controller and Cao
Officer
|
Nov 1, 2024 | 1,720 | $16,271 | 92,350 (-1.9%) | Payment of Exercise Price | |
|
Executive Chairman of Board
Director, Officer, 10% Owner
|
Nov 1, 2024 | 19,438 | $183,883 | 1,471,123 (-1.3%) | Payment of Exercise Price | |
|
Svp, Chief Pharmacy Officer
Officer
|
Nov 1, 2024 | 68,182 | $10,000 | 147,655 (+46.2%) | Grant | |
|
Svp, Chief Pharmacy Officer
Officer
|
Nov 1, 2024 | 4,915 | $46,496 | 141,520 (-3.5%) | Payment of Exercise Price | |
|
EVP and Global CFO
Officer
|
Nov 1, 2024 | 455 | $4,304 | 418,829 (-0.1%) | Payment of Exercise Price | |
|
Evp, Global Chief Hr Officer
Officer
|
Nov 1, 2024 | 147,059 | $0 | 311,381 (+47.2%) | Grant | |
|
Chief Corp. Affairs Officer
Officer
|
Nov 1, 2024 | 72,193 | $0 | 127,097 (+56.8%) | Grant | |
|
Chief Corp. Affairs Officer
Officer
|
Nov 1, 2024 | 3,967 | $37,528 | 123,130 (-3.2%) | Payment of Exercise Price | |
|
Chief Executive Officer
Director, Officer
|
Nov 1, 2024 | 762,032 | $0 | 1,376,518 (+55.4%) | Grant | |
|
Evp, Pres., Walgreens Retail
Officer
|
Nov 1, 2024 | 167,647 | $0 | 357,612 (+46.9%) | Grant | |
|
Evp, Pres., Walgreens Retail
Officer
|
Nov 1, 2024 | 3,089 | $29,222 | 353,485 (-0.9%) | Payment of Exercise Price | |
|
Evp, Chief Information Officer
Officer
|
Nov 1, 2024 | 193,583 | $0 | 401,878 (+48.2%) | Grant | |
|
Evp, Chief Information Officer
Officer
|
Nov 1, 2024 | 5,367 | $50,772 | 379,683 (-1.4%) | Payment of Exercise Price | |
|
Svp, Global Controller and Cao
Officer
|
Nov 1, 2024 | 50,802 | $0 | 94,786 (+53.6%) | Grant | |
|
Evp, President U.s. Healthcare
Officer
|
Nov 1, 2024 | 256,684 | $10,000 | 519,600 (+49.4%) | Grant | |
|
Svp, Chief Pharmacy Officer
Officer
|
Nov 1, 2024 | 213 | $2,015 | 147,442 (-0.1%) | Payment of Exercise Price | |
|
Svp, Chief Pharmacy Officer
Officer
|
Nov 1, 2024 | 1,007 | $9,526 | 146,435 (-0.7%) | Payment of Exercise Price | |
|
Chief Operating Officer, Int'l
Officer
|
Nov 1, 2024 | 303,476 | $0 | 972,522 (+31.2%) | Grant | |
|
Svp, Global Controller and Cao
Officer
|
Nov 1, 2024 | 213 | $2,015 | 94,573 (-0.2%) | Payment of Exercise Price | |
|
Director
|
Nov 1, 2024 | 14,799 | $10,000 | 16,495 (+89.7%) | Grant | |
|
Director
|
Nov 1, 2024 | 21,141 | $10,000 | 21,141 (+100.0%) | Grant | |
|
Svp, Global Controller and Cao
Officer
|
Nov 1, 2024 | 503 | $4,758 | 94,070 (-0.5%) | Payment of Exercise Price | |
|
Director
|
Nov 1, 2024 | 3,523 | $10,000 | 3,523 (+100.0%) | Grant | |
|
Director
|
Nov 1, 2024 | 21,141 | $10,000 | 30,835 (+68.6%) | Grant | |
|
Evp, Pres., Walgreens Retail
Officer
|
Nov 1, 2024 | 1,038 | $9,819 | 356,574 (-0.3%) | Payment of Exercise Price | |
|
Evp, Chief Information Officer
Officer
|
Nov 1, 2024 | 16,828 | $159,193 | 385,050 (-4.4%) | Payment of Exercise Price | |
|
EVP and Global CFO
Officer
|
Nov 1, 2024 | 3,686 | $34,870 | 414,064 (-0.9%) | Payment of Exercise Price | |
|
EVP and Global Clo
Officer
|
Nov 1, 2024 | 166,310 | $0 | 356,924 (+46.6%) | Grant | |
|
Chief Operating Officer, Int'l
Officer
|
Nov 1, 2024 | 18,201 | $172,181 | 954,321 (-1.9%) | Payment of Exercise Price | |
|
EVP and Global CFO
Officer
|
Nov 1, 2024 | 243,316 | $0 | 419,284 (+58.0%) | Grant | |
|
Chief Executive Officer
Director, Officer
|
Nov 1, 2024 | 78,142 | $739,223 | 1,298,376 (-6.0%) | Payment of Exercise Price | |
|
Evp, Pres., Walgreens Retail
Officer
|
Nov 1, 2024 | 11,993 | $113,454 | 341,492 (-3.5%) | Payment of Exercise Price | |
|
EVP and Global CFO
Officer
|
Nov 1, 2024 | 1,079 | $10,207 | 417,750 (-0.3%) | Payment of Exercise Price | |
|
EVP and Global CFO
Officer
|
Oct 23, 2024 | 4,544 | $0 | 177,299 (+2.6%) | Grant | |
|
Svp, Chief Pharmacy Officer
Officer
|
Oct 23, 2024 | 621 | $5,806 | 79,473 (-0.8%) | Payment of Exercise Price | |
|
Evp, Pres., Walgreens Retail
Officer
|
Oct 23, 2024 | 10,602 | $10,000 | 193,156 (+5.5%) | Grant | |
|
Svp, Global Controller and Cao
Officer
|
Oct 23, 2024 | 2,120 | $10,000 | 44,605 (+4.8%) | Grant | |
|
Executive Chairman of Board
Director, Officer, 10% Owner
|
Oct 23, 2024 | 374,883 | $0 | 1,490,561 (+25.2%) | Grant | |
|
Svp, Chief Pharmacy Officer
Officer
|
Oct 23, 2024 | 2,120 | $0 | 80,094 (+2.6%) | Grant | |
|
Svp, Global Controller and Cao
Officer
|
Oct 23, 2024 | 621 | $5,806 | 43,984 (-1.4%) | Payment of Exercise Price | |
|
Evp, Pres., Walgreens Retail
Officer
|
Oct 23, 2024 | 3,191 | $29,836 | 189,965 (-1.7%) | Payment of Exercise Price | |
|
Chief Operating Officer, Int'l
Officer
|
Oct 23, 2024 | 27,263 | $0 | 672,887 (+4.1%) | Grant | |
|
Chief Operating Officer, Int'l
Officer
|
Oct 23, 2024 | 3,841 | $37,373 | 669,046 (-0.6%) | Payment of Exercise Price | |
|
EVP and Global CFO
Officer
|
Oct 23, 2024 | 1,331 | $12,445 | 175,968 (-0.8%) | Payment of Exercise Price | |
| Sep 11, 2024 | 11,619,998 | $1,512,000,000,000 | 23,239,996 (-50.0%) | Sale | ||
| Aug 1, 2024 | 4,438,171 | $1,067,646,416 | 19,980,000 (-22.2%) | Sale |